By Catherine Eckford (European Pharmaceutical Review)2024-01-29T20:43:00
Included in the revised ISO 10993-17 guideline are requirements for toxicological risk assessment of medical device constituents, such as extractables and leachables (E&L).
Already a member? Sign-in
European Pharmaceutical Review delivers authoritative insights, cutting-edge innovations, and expert perspectives that not only inform decisions but drive measurable progress across quality, compliance, and operational excellence.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-05-12T07:43:00Z
Sponsored by Sartorius, By European Pharmaceutical Review
2026-04-30T10:37:00
Sponsored by Shimadzu
2026-03-27T15:37:00
Sponsored by IMA Pharma
2026-03-18T15:00:00
Sponsored by Sartorius
2025-07-25T08:10:00
Sponsored by JRS Pharma and Gattefosse, By European Pharmaceutical Review
2025-10-22T14:00:00
Sponsored by Bruker
2026-02-19T15:00:00 2026-02-19T16:00:00
Sponsored by Veolia
Site powered by Webvision Cloud